N
Nykode Therapeutics ASA
F:5VB
Nykode Therapeutics ASA
F:5VB
Price:
0.382
EUR
-12.69%
Market Closed
Market Cap:
€560.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Nykode Therapeutics ASA
F:5VB
|
NO |
|
Sixty North Gold Mining Ltd
F:2F40
|
CA |
|
Quilter PLC
F:2FQ0
|
UK |
|
C
|
Cassiar Gold Corp
F:756
|
CA |
|
C
|
Credit Acceptance Corp
F:2D5
|
US |
|
Modelon AB (publ)
F:3VM
|
SE |
|
Nuformix PLC
F:1RT
|
UK |
|
Marinomed Biotech AG
F:93Z
|
AT |
|
I
|
ICON PLC
F:IJF
|
IE |
|
Marvel Gold Ltd
F:GR2
|
AU |
|
D
|
DevvStream Corp
OTC:DEVSF
|
US |
|
P
|
Probiotec Ltd
XBER:PG3
|
AU |
|
H
|
Hirose Electric Co Ltd
F:HRO
|
JP |
|
Gusbourne PLC
F:S8E
|
UK |
|
Zueblin Immobilien Holding AG
F:61Z
|
CH |
|
Aion Therapeutic Inc
OTC:ANTCF
|
CA |
|
Fast Finance 24 Holding AG
F:FF24
|
DE |
Wall St Price Targets
5VB Price Targets Summary
Nykode Therapeutics ASA
Nykode Therapeutics ASA
Wall Street analysts forecast 5VB stock price to drop over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 5VB is 0.233 EUR with a low forecast of 0.203 EUR and a high forecast of 0.268 EUR.
Lowest Forecast
Price Target
0.203
EUR
47% Downside
Average Forecast
Price Target
0.233
EUR
39% Downside
Highest Forecast
Price Target
0.268
EUR
30% Downside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 5VB's stock price target?
Price Target
0.233
EUR
0.233
EUR
According to Wall Street analysts, the average 1-year price target for 5VB is 0.233 EUR with a low forecast of 0.203 EUR and a high forecast of 0.268 EUR.
